Cargando…
Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis
Although fingolimod and interferon-β are two mechanistically different multiple sclerosis (MS) treatments, they both induce B cell activating factor (BAFF) and shift the B cell pool towards a regulatory phenotype. However, whether there is a shared mechanism between both treatments in how they influ...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187869/ https://www.ncbi.nlm.nih.gov/pubmed/34122439 http://dx.doi.org/10.3389/fimmu.2021.676619 |